Do children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy?
BMC Cancer 2012, 12:314 doi:10.1186/1471-2407-12-314
Pre-publication versions of this article and reviewers' reports
|Original Submission - Version 1||16 May 2012|
|Resubmission - Version 2||20 Jun 2012|
|Editor's comment||06 Jul 2012|
|Editorial acceptance||06 Jul 2012|
|Published||26 Jul 2012|